Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-01

Clinical Trial Update: Exendin-9,39 and Satiety After Bariatric Surgery [NA]

View source ↗

Summary

A completed clinical trial investigating Exendin-9,39 and satiety after bariatric surgery for obesity; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exendin 9-39 (exendin-9-39)

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity | NA | Status: COMPLETED | Results posted: 2020-05-01